The investigation of a novel, cheaper method of diagnosing inflammatory bowel disease
(IBD) is an area of active research. Recently, investigations into the metabolomic profile of …

Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …

The diagnosis of inflammatory bowel disease (IBD) remains a challenging task despite
significant increase in the understanding of the disease aetiology and pathogenesis. Recent …

Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to
invasive investigations in order to rule out other diseases and reassure their patients …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

OBJECTIVES: The accuracy of available noninvasive biomarkers for diagnosis, stratification,
and prediction of inflammatory bowel disease (IBD) courses is limited. We analyzed volatile …

Background Inflammatory bowel disease (IBD) is diagnosed and monitored using
endoscopic assessment, which is invasive and costly. In this study, potential of faecal …

Metabolomics studies have the potential to discover biomarkers. Fecal volatile organic
compounds (VOCs) have been found to differ in patients with inflammatory bowel disease …

Background Disappearance of macroscopic mucosal inflammation predicts long-term
outcome in Crohn's disease (CD). It can be assessed by ileocolonoscopy, which is …

Introduction: Inflammatory bowel disease (IBD) is a common disease with significant
morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin …